ISSN: 2211-0348

Journal Home

Journal Guideline

Multiple Sclerosis and Related Disorders Q1 Unclaimed

Elsevier B.V. Netherlands

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Multiple Sclerosis and Related Disorders is a journal indexed in SJR in Medicine (miscellaneous) and Neurology (clinical) with an H index of 63. It has an SJR impact factor of 0,99 and it has a best quartile of Q1. It has an SJR impact factor of 0,99.

Multiple Sclerosis and Related Disorders focuses its scope in these topics and keywords: multiple, sclerosis, patients, fingolimod, treatment, disorder, outcomes, spectrum, neuromyelitis, questionnaire, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) (Q1) Neurology (Q2) Neurology (clinical) (Q2) Neurology (clinical) (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Multiple Sclerosis and Related Disorders

0,99

SJR Impact factor

63

H Index

534

Total Docs (Last Year)

2026

Total Docs (3 years)

21034

Total Refs

5555

Total Cites (3 years)

1701

Citable Docs (3 years)

2.7

Cites/Doc (2 years)

39.39

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Nature Biomedical Engineering Q1
Journal of Thoracic Oncology Q1
Annual Review of Clinical Psychology Q1
Lancet Digital Health, The Q1
Journal of Experimental Medicine Q1

Compare this journals

Aims and Scope

Best articles by citations

Four-year Expanded Disability Status Scale (EDSS) outcomes in patients treated with fingolimod in the Phase 3 and extension trial program

Inflammatory cytokines in relapsing-remitting multiple sclerosis (RRMS) patients

Epstein-Barr virus candidate genes and multiple sclerosis

Role of microchimeric cells in pathogenesis of multiple sclerosis

Metabolomic profile of insulin resistance in patients with multiple sclerosis is associated to the severity of the disease

Cumulative review of thrombotic microangiopathy, thrombotic thrombocytopenic purpura and hemolytic uremic syndrome reports with SC interferon beta-1a

Increased deep gray matter iron is present in clinically isolated syndromes

MRI in NMO: How to differentiate from MS

Natalizumab reduces relapse clinical severity and improves relapse recovery in MS

MRI in the management of MS

Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoring

Vitamin A is not associated with exacerbations in multiple sclerosis

SHOW MORE ARTICLES

Phase sensitive reconstruction of T1-weighted inversion recovery in the evaluation of the cervical cord lesions in Multiple Sclerosis; is it similarly eligible in 1.5 T magnet fields?

Efficacy and safety of fingolimod treatment in multiple sclerosis: The clinical experience of the AUBMC Multiple Sclerosis Center in Lebanon

Cortical demyelination in MS

Assessment of multiple sclerosis awareness and knowledge among the Saudi population in Riyadh City

A retrospective cohort study of plasma exchange in central nervous system demyelinating events in children

Role of histamine and diamine oxidase enzyme in Multiple Sclerosis

Multiple sclerosis and pregnancy

Efficacy of lower fingolimod doses in the treatment of MS

LIF and multiple sclerosis: One protein with two healing properties

Effects of recurrent fasting on fatigue and quality of life in patients with multiple sclerosis

Sulcal and gyral crown cortical grey matter involvement in multiple sclerosis: A magnetisation transfer ratio study

Investigation of Oncostatin M protein expression in Iranian relapsing remitting multiple sclerosis patients